Tag: Genentech

Can We Make Quality of Life a Priority in SSF?

South San Francisco, CA    March 9, 2018  by  Mel Ellison, ESC Correspondent Like the rumbling of a jet on takeoff from SFO, the sound of discontent can be heard throughout South San Francisco, but are our City officials listening? The…

Phase III IMpower150 Study Showed Genentech’s Tecentriq (Atezolizumab) and Avastin (Bevacizumab) Plus Chemotherapy Significantly Reduced the Risk of Disease Worsening or Death in the Initial Treatment of People with a Type of Advanced Lung Cancer

South San Francisco, CA  November 29, 2017 Genentech Press Release – Data will be submitted to health authorities globally, including the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) – SOUTH SAN FRANCISCO, CA — 2017-11-19 00:00:00 Genentech,…